Effects of osteogenic differentiation inducers on in vitro expanded adult mesenchymal stromal cells

International Journal of Artificial Organs

Volumn 34, Issue 10, 2011, Pages 998-1011

  Fiorentini, Elisa ^a   Granchi, Donatella ^a   Leonardi, Elisa ^a   Baldini, Nicola ^a,b   Ciapetti, Gabriela ^a  

^a RIZZOLI ORTHOPAEDIC INSTITUTE   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Bone; Human mesenchymal cells; Osteogenic differentiation

Indexed keywords

ALKALINITY; ASCORBIC ACID; COLLAGEN; CYTOLOGY; GENE EXPRESSION; HIP PROSTHESES; MINERALOGY; PHOSPHATASES; PHOSPHOLIPIDS; STEM CELLS;

BASAL MEDIUM; CELL-BE; CELL/B.E; DEXAMETHASONES; GLYCEROPHOSPHATE; HUMAN MESENCHYMAL CELLS; IN-VITRO; MESENCHYMAL STROMAL CELLS; OSTEOGENIC; OSTEOGENIC DIFFERENTIATION;

BONE;

ALKALINE PHOSPHATASE; ASCORBIC ACID; COLLAGEN TYPE 1; DEXAMETHASONE; GLYCEROL 2 PHOSPHATE; OSTEOCALCIN; TRANSCRIPTION FACTOR RUNX2;

ADULT; AGED; ARTICLE; BONE DEVELOPMENT; BONE MINERALIZATION; CELL CULTURE; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL STRUCTURE; COLONY FORMING UNIT; CULTURE MEDIUM; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; IN VITRO STUDY; MALE; MESENCHYMAL STROMAL CELL; MESENCHYME CELL; NUCLEOTIDE SEQUENCE; STROMA CELL; TOTAL HIP PROSTHESIS;

EID: 83455205863     PISSN: 03913988     EISSN: None     Source Type: Journal    
DOI: 10.5301/ijao.5000001     Document Type: Article

References (56)

1. Bajada S, Mazakova I, Richardson JB, Ashammakhi N. Updates on stem cells and their applications in regenerative medicine. J Tissue Eng Regener Med. 2008;2(4):169-183. doi:10.1002/term.83.
2. Lepperdinger G, Brunauer R, Jamnig A, Laschober G, Kassem M. Controversial issue: Is it safe to employ mesenchymal stem cells in cell-based therapies? Exp Gerontol. 2008;43(11):1018-1023. Medline. doi:10.1016/j. exger.2008.07.004.
3. Digirolamo CM, Stokes D, Colter D, Phinney DG, Class R, Prockop DJ. Propagation and senescence of human marrow stromal cells in culture: a simple colony forming assay identifies samples with the greatest potential to propagate and differentiate. Br J Haematol. 1999;107(2):275-281. Medline. doi:10.1046/j.1365-2141.1999.01715.x.
4. Stenderup K, Justesen J, Clausen C, Kassem M. Aging is associated with decreased maximal life span and accelerated senescence of bone marrow stromal cells. Bone. 2003;33(6):919-926. Medline. doi:10.1016/j. bone.2003.07.005.
5. Stolzing A, Jones E, McGonagle D, Scutt A. Age-related changes in human bone marrow-derived mesenchymal stem cells: Consequences for cell therapies. Mech Ageing Dev. 2008;129(3):163-173. Medline. doi:10.1016/j. mad.2007.12.002.
6. Bartmann C, Rohde E, Schallmoser K, et al. Two steps to functional mesenchymal stromal cells for clinical application. Transfusion. 2007;47(8):1426-1435. Medline. doi:10.1111/ j.1537-2995.2007.01219.x.
7. Brinchmann JE. Expanding autologous multipotent mesenchymal bone marrow stromal cells. J Neurol Sci. 2008;265(1- 2):127-130. Medline. doi:10.1016/j.jns.2007.05.006.
8. Sands RW, Mooney DJ. Polymers to direct cell fate by controlling the microenvironment. Curr Opin Biotechnol. 2007;18(5):448-453. Medline. doi:10.1016/j.copbio. 2007.10.004.
9. Heng BC, Cao T, Stanton LW, Robson P, Olsen B. Strategies for directing the differentiation of stem cells into the osteogenic lineage in vitro. J Bone Miner Res. 2004;19(9):1379-1394. Medline. doi:10.1359/JBMR.040714.
10. Pittenger MF, Mackay AM, Beck SC, et al. Multilineage potential of adult human mesenchymal stem cells. Science. 1999;284(5411):143-147. Medline. doi:10.1126/science. 284.5411.143.
11. Javazon EH, Beggs KJ, Flake AW. Mesenchymal stem cells: Paradoxes of passaging. Exp Hematol. 2004;32(5):414-425. Medline. doi:10.1016/j.exphem.2004.02.004.
12. Chen XD, Dusevich V, Feng JQ, Manolagas SC, Jilka RL. Extracellular matrix made by bone marrow facilitates expansion of marrow-derived mesenchymal progenitor cells and prevents their differentiation into osteoblasts. J Bone Miner Res. 2007;22(12):1943-1956. Medline. doi:10.1359/jbmr.070725.
13. Song IH, Caplan AI, Dennis JE. In vitro dexamethasone pretreatment enhances bone formation of human mesenchymal stem cells in vivo. J Orthop Res. 2009;27(2):216-221. Medline. doi:10.1002/jor.20726.
14. Choi KM, Seo YK, Yoon HH, et al. Effect of ascorbic acid on bone marrow-derived mesenchymal stem cell proliferation and differentiation. J Biosci Bioeng. 2008;105(6):586-594. Medline. doi:10.1263/jbb.105.586.
15. Porter RM, Huckle WR, Goldstein AS. Effect of dexamethasone withdrawal on osteoblastic differentiation of bone marrow stromal cells. J Cell Biochem. 2003;90(1):13-22. Medline. doi:10.1002/jcb.10592.
16. Jørgensen NR, Henriksen Z, Sorensen OH, Civitelli R. Dexamethasone, BMP-2, and 1,25-dihydroxyvitamin D enhance a more differentiated osteoblast phenotype: validation of an in vitro model for human bone marrow-derived primary osteoblasts. Steroids. 2004;69(4):219-226. Medline. doi:10.1016/j. steroids.2003.12.005.
17. Fromigué O, Marie PJ, Lomri A. Differential effects of Transforming Growth Factor β2, dexamethasone and 1,25-dihydroxyvitamin D on human bone marrow stromal cells. Cytokine. 1997;9(8):613-623. Medline. doi:10.1006/ cyto.1997.0209.
18. Frölke JP, Nulend JK, Semeins CM, et al. Viable osteoblastic potential of cortical reamings from intramedullary nailing. J Orthop Res. 2004;22(6):1271-1275. Medline. doi:10.1016/j. orthres.2004.03.011.
19. Hoemann CD, El-Gabalawy H, McKee MD. In vitro osteogenesis assays: influence of the primary cell source on alkaline phosphatase activity and mineralization. Pathol Biol (Paris). 2009;57(4):318-323. Medline. doi:10.1016/j.patbio. 2008.06.004.
20. Mauney JR, Volloch V, Kaplan DL. Role of adult mesenchymal stem cells in bone tissue-engineering applications: current status and future prospects. Tissue Eng. 2005;11(5-6):787-802. Medline. doi:10.1089/ ten.2005.11.787.
21. Bianco P, Robey PG. Marrow stromal cells. J Clin Invest. 2000;105(12):1663-1668. Medline. doi:10.1172/JCI10413.
22. Gronthos S, Simmons PJ, Graves SE, Robey PG. Integrin mediated interactions between human bone marrow stromal precursor cells and the extracellular matrix. Bone. 2001;28(2):174-181. Medline. doi:10.1016/S8756- 3282(00)00424-5.
23. Datta N, Holtorf HL, Sikavitsas VI, et al. Effect of bone extracellular matrix synthesized in vitro on the osteoblastic differentiation of marrow stromal cells. Biomaterials. 2005;26(9):971-977. Medline. doi:10.1016/j.biomaterials. 2004.04.001.
24. Rhodes JM, Simons M. The extracellular matrix and blood vessel formation: not just a scaffold. J Cell Mol Med. 2007;11(12):176-205. Medline. doi:10.1111/j.1582- 4934.2007.00031.x.
25. Franceschi RT. Biological Approaches to Bone Regeneration by Gene Therapy. J Dent Res. 2005;84(12):1093-1103. Medline. doi:10.1177/154405910508401204.
26. Khan Y, Yaszemski MJ, Mikos AG, et al. Tissue engineering of bone: material and matrix considerations. J Bone Joint Surg Am. 2008;90 (Suppl 1):36-42. Medline. doi:10.2106/ JBJS.G.01260.
27. Born AK, Rottmar M, Lischer S, Pleskova M, Bruinink A, Maniura-Weber K. Correlating cell architecture with osteogenesis: first steps toward live single cell monitoring. Eur Cell Mater. 2009;18:49-60. Medline.
28. van Gaalen SM, De Brujin JD, Wilson CE, et al. Relating cell proliferation to in vivo bone formation in porous Ca/P scaffolds. J Biomed Mater Res A. 2010;92(1):303-310 Medline. doi:10.1002/jbm.a.32380.
29. Koller MR, Palsson MA, Manchel I, et al. Tissue culture surface characteristics influence the expansion of human bone marrow cells. Biomaterials. 1998;19(21):1963-1972. Medline. doi:10.1016/S0142-9612(98)00101-X.
30. Sotiropoulou PA, Perez SA, Salagianni M, et al. Characterization of the optimal culture conditions for clinical scale production of human mesenchymal stem cells. Stem Cells. 2006;24(2):462-471. Medline. doi:10.1634/stemcells. 2004-0331.
31. Lapi S, Nocchi F, Lamanna R, et al. Different media and supplements modulate the clonogenic and expansion properties of rabbit bone marrow mesenchymal stem cells. BMC Res Notes. 2008;1:53. Medline. doi:10.1186/1756- 0500-1-53.
32. Both SK, Van der Muijsenberg AJC, Van Blitterswijk CA, De Boer J, De Bruijn JD. A rapid and efficient method for expansion of human mesenchymal stem cells. Tissue Eng. 2007;13(1):3-9. Medline. doi:10.1089/ten.2005.0513.
33. Pytlík R, Stehlik D, Soukup T, et al. The cultivation of human multipotent mesenchymal stromal cells in clinical grade medium for bone tissue engineering. Biomaterials. 2009;30(20):3415-3427 Medline. doi:10.1016/j.biomaterials. 2009.03.001.
34. Sotiropoulou PA, Perez SA, Salagianni M, Baxevanis CN, Papamichail M. Cell culture medium composition and translational adult bone marrow-derived stem cell research. Stem Cells. 2006;24(5):1409-1410. Medline. doi:10.1634/stemcells. 2005-0654.
35. Salvadè A, Della Mina P, Gaddi D, et al. Characterization of platelet lysate (PL)-cultured mesenchymal stromal cells (MSC) and their potential use in tissue-engineered osteogenic devices for the treatment of bone defects. Tissue Eng Part C Methods. 2010;16(2):201-214. Medline. doi:10.1089/ ten.tec.2008.0572.
36. Tonti GA, Mannello F. From bone marrow to therapeutic applications: different behaviour and genetic/epigenetic stability during mesenchymal stem cell expansion in autologous and foetal bovine sera? Int J Dev Biol. 2008;52(8):1023-1032. Medline. doi:10.1387/ijdb.082725gt.
37. Satija NK, Gurudutta GU, Sharma S, et al. Mesenchymal stem cells: molecular targets for tissue engineering. Stem Cells Dev. 2007;16(1):7-23. Medline. doi:10.1089/ scd.2006.9998.
38. Pal R, Hanwate M, Jan M, Totey S. Phenotypic and functional comparison of optimum culture conditions for upscaling of bone marrow-derived mesenchymal stem cells. J Tissue Eng Regener Med. 2009;3(3):163-174. doi:10.1002/term.143.
39. Bonab M, Alimoghaddam K, Talebian F, Ghaffari SH, Ghavamzadeh A, Nikbin B. Aging of mesenchymal stem cell in vitro. BMC Cell Biol. 2006;(7):7-14. Medline.
40. Castano-Izquierdo H, Alvarez-Barreto J, Van den Dolder J, Jansen JA, Mikos AG, Sikavitsas VI. Pre-culture period of mesenchymal stem cells in osteogenic media influences their in vivo bone forming potential. J Biomed Mater Res A. 2007;82(1):129-138. Medline. doi:10.1002/jbm.a.31082.
41. Stein GS, Lian JB. Molecular Mechanisms Mediating Proliferation/ Differentiation Interrelationship During Progressive Development of the Osteoblast Phenotype. Endocr Rev. 1993;14(4):424-442. Medline.
42. Porter RM, Liu F, Pilapil C, et al. Osteogenic potential of reamer irrigator aspirator (RIA) aspirate collected from patients undergoing hip arthroplasty. J Orthop Res. 2009;27(1):42-49. Medline. doi:10.1002/jor.20715.
43. Ishikawa S, Isawaki K, Komaki M, Ishikawa I. Role of ascorbic acid in periodontal ligament cell differentiation. J Periodontol. 2004;75(5):709-716. Medline. doi:10.1902/ jop.2004.75.5.709.
44. Takamizawa S, Maehata Y, Imai K, Senoo H, Sato S, Hata R. Effects of ascorbic acid and ascorbic acid 2-phosphate, a long-acting vitamin C derivative, on the proliferation and differentiation of human osteoblast-like cells. Cell Biol Int. 2004;28(4):255-265. Medline. doi:10.1016/j.cellbi. 2004.01.010.
45. Wagner W, Feldmann RE Jr, Seckinger A, et al. The heterogeneity of human mesenchymal stem cell preparations - Evidence from simultaneous analysis of proteomes and transcriptomes. Exp Hematol. 2006;34(4):536-548. Medline. doi:10.1016/j.exphem.2006.01.002.
46. Coelho MJ, Fernandes MH. Human bone cell cultures in biocompatibility testing. Part II: effect of ascorbic acid, bglycerophosphate and dexamethasone on osteoblastic differentiation. Biomaterials. 2000;21(11):1095-1102. Medline. doi:10.1016/S0142-9612(99)00192-1.
47. Pri-Chen S, Pitaru S, Lokiec F, Savion N. Basic Fibroblast Growth Factor enhances the growth and expression of the osteogenic phenotype of dexamethasone-treated human bone marrow-derived bone-like cells in culture. Bone. 1998;23(2):111-117. Medline. doi:10.1016/S8756-3282(98)00087-8.
48. Schecroun N, Delloye CH. Bone-like nodules formed by human bone marrow stromal cells: comparative study and characterization. Bone. 2003;32(3):252-260. Medline. doi:10.1016/S8756-3282(02)00970-5.
49. Mendes SC, Tibbe JM, Veenhof M, et al. Relation between in vitro and in vivo osteogenic potential of cultured human bone marrow stromal cells. J Mater Sci Mater Med. 2004;15(10):1123-1128. Medline. doi:10.1023/ B:JMSM.0000046394.53153.21.
50. Chang PL, Blair HC, Zhao Z, et al. Comparison of Fetal and Adult Marrow Stromal Cells in Osteogenesis with and without Glucocorticoids. Connect Tissue Res. 2006;47(2):67-76. Medline. doi:10.1080/03008200600584074.
51. Agata H, Asahina I, Watanabe N, et al. Characteristic Change and Loss of In Vivo Osteogenic Abilities of Human Bone Marrow Stromal Cells During Passages. Tissue Eng Part A. 2010;16(2):663-673. Medline. doi:10.1089/ten. tea.2009.0500.
52. Oshina H, Sotome S, Yoshii T, et al. Effects of continuous dexamethasone treatment on differentiation capabilities of bone marrow-derived mesenchymal cells. Bone. 2007;41(4):575-583. Medline. doi:10.1016/j. bone.2007.06.022.
53. Song IH, Caplan AI, Dennis JE. Dexamethasone Inhibition of Confluence-Induced Apoptosis in Human Mesenchymal Stem Cells. J Orthop Res. 2009;27(7):916-921. Medline. doi:10.1002/jor.20838.
54. Beck GR, Zerler B, Moran E. Phosphate is a specific signal for induction of osteopontin gene expression. Proc Natl Acad Sci USA. 2000;97(15):8352-8357. Medline. doi:10.1073/pnas.140021997.
55. Lund AW, Yener B, Stegemann JP, Plopper GE. The natural and engineered 3D microenvironment as a regulatory cue during stem cell fate. Tissue Eng Part B Rev. 2009;15(3):371-380. Medline.
56. Winer JP, Janmey PA, McCormick ME, Funaki M. Bone marrow-derived human mesenchymal stem cells become quiescent on soft substrates but remain responsive to chemical or mechanical stimuli. Tissue Eng Part A. 2009;15(1):147-154. doi:10.1089/ten.tea.2007.0388.